MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Eli Lilly

  • EU Slaps Tariffs on Chinese EVs | Business Matters (Oct. 30)
    EU Slaps Tariffs on Chinese EVs | Business Matters (Oct. 30)
    The European Union has increased tariffs on Chinese-built electric vehicles to as much as 45.3 percent at the end of its highest-profile trade investigation that has divided Europe and prompted ...
    October 30, 2024BY Don Ma
  • The Market Might As Well Close Every August
    The Market Might As Well Close Every August
    Commentary Every year, I wonder why the stock market doesn’t close in August since so many traders go ...
    August 13, 2024BY Louis Navellier
  • JP Morgan: Recession Now More Likely; Average American Now Carrying Over $6,300 in Credit Card Debt | Business Matters Full Broadcast (Aug. 8)
    JP Morgan: Recession Now More Likely; Average American Now Carrying Over $6,300 in Credit Card Debt | Business Matters Full Broadcast (Aug. 8)
    JP Morgan is now raising the odds of a recession by the end of this year to 35 ...
    August 8, 2024BY Don Ma
  • Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
    January 8, 2024BY A.C. Dahnke
  • Eli Lilly Launches Digital Health Care Platform to Help Patients With Chronic Disease
    Eli Lilly Launches Digital Health Care Platform to Help Patients With Chronic Disease
    The new digital health care platform facilitates home delivery for patients, ensuring they have 'consistent access' to Lilly ...
    January 5, 2024BY Aldgra Fredly
  • Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
    December 1, 2023BY Lorenz Duchamps
  • Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
    Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
    As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over ...
    November 1, 2023BY Mary Gillis
  • Eli Lilly Sues Clinics Over Alleged Sales of Unapproved Versions of Diabetes Drug
    Eli Lilly Sues Clinics Over Alleged Sales of Unapproved Versions of Diabetes Drug
    Pharmaceutical giant Eli Lilly has filed a lawsuit against multiple medical spas, wellness centers, and compounding pharmacies across ...
    September 20, 2023BY Katabella Roberts
  • Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
    Top 5 US Pharma Companies Netted $82 Billion in 2022: Report
    The five largest pharmaceutical companies in the United States netted approximately $81.9 billion last year, according to a ...
    July 25, 2023BY Ryan Morgan
  • UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
    June 28, 2023BY Harry Lee
  • Sen. Sanders Asks Insulin Manufacturers to Testify Before Senate HELP Panel
    Sen. Sanders Asks Insulin Manufacturers to Testify Before Senate HELP Panel
    Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bernie Sanders has called the executives of top insulin ...
    April 21, 2023BY Joseph Lord
  • Major Drugmaker to Cut Insulin Prices for Americans
    Major Drugmaker to Cut Insulin Prices for Americans
    Eli Lilly and Co. announced on Wednesday that prices for the company's most commonly prescribed insulins will be ...
    March 1, 2023BY Lorenz Duchamps
  • FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab
    FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab
    Eli Lilly and Co.'s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, ...
    December 3, 2022BY Reuters
  • Alzheimer’s Drug Breakthrough Big Boost for Roche, Eli Lilly
    Alzheimer’s Drug Breakthrough Big Boost for Roche, Eli Lilly
    LONDON—The results of a key Alzheimer's drug trial on Wednesday have reignited decades-old hopes that targeting a particular ...
    September 29, 2022BY Reuters
  • Eli Lilly Sued for Age Discrimination by US Agency EEOC
    Eli Lilly Sued for Age Discrimination by US Agency EEOC
    Eli Lilly and Co. was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the ...
    September 27, 2022BY Reuters
  • Major Drug Company Announces Change Over Indiana’s Abortion Ban
    Major Drug Company Announces Change Over Indiana’s Abortion Ban
    Pharmaceutical giant Eli Lilly said it is looking to expand its Indiana-based headquarters outside the state after Indiana ...
    August 7, 2022BY Jack Phillips
  • FDA Rejects Eli Lilly’s China-Developed Cancer Drug
    FDA Rejects Eli Lilly’s China-Developed Cancer Drug
    The U.S. Food and Drug Administration has declined to approve a lung cancer drug U.S. drugmaker Eli Lilly ...
    March 25, 2022BY Frank Fang
  • FDA Restricts Use of 2 Monoclonal Antibody Treatments
    FDA Restricts Use of 2 Monoclonal Antibody Treatments
    The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal ...
    January 25, 2022BY Mimi Nguyen Ly
  • Judge Hears Opening Arguments on Biden Administration’s Alleged Purge of Industry From EPA Panels
    Judge Hears Opening Arguments on Biden Administration’s Alleged Purge of Industry From EPA Panels
    Judge Timothy Kelly of the U.S. District Court for the District of Columbia heard opening arguments on Dec. ...
    December 23, 2021BY Nathan Worcester
  • Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their ...
    December 16, 2021BY Reuters
  • FDA Authorizes Eli Lilly’s COVID-19 Antibody Therapy for Children
    FDA Authorizes Eli Lilly’s COVID-19 Antibody Therapy for Children
    The Food and Drug Administration (FDA) on Friday expanded its emergency use authorization (EUA) of Eli Lilly and ...
    December 3, 2021BY Mimi Nguyen Ly
  • FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization
    FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization
    Eli Lilly’s COVID-19 antibody-drug has been granted emergency use authorization by the Food and Drug Administration (FDA), widening ...
    February 10, 2021BY Isabel van Brugen
  • FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a ...
    November 10, 2020BY Isabel van Brugen
  • Antibody Treatment Shows Improvement in Patients With Mild to Moderate Infection
    Antibody Treatment Shows Improvement in Patients With Mild to Moderate Infection
    Eli Lilly’s neutralizing antibody LY-CoV555 has shown improvement in treating patients with mild to moderate cases of the CCP ...
    October 30, 2020BY Paula Liu
  • NIH Announces Halt to Eli Lilly Antibody Treatment on Hospitalized COVID-19 Patients
    NIH Announces Halt to Eli Lilly Antibody Treatment on Hospitalized COVID-19 Patients
    The National Institute of Allergy and Infectious Diseases (NIAID) announced in a statement that they have stopped clinical trials of ...
    October 27, 2020BY Paula Liu
  • Eli Lilly Pauses COVID-19 Drug Trial Due to Safety Concerns
    Eli Lilly Pauses COVID-19 Drug Trial Due to Safety Concerns
    Eli Lilly announced on Tuesday that the government-sponsored clinical trial of its COVID-19 monoclonal antibody treatment has been ...
    October 14, 2020BY Tom Ozimek
  • Drugmaker Eli Lilly Caps Insulin Costs at $35 as CCP Virus Crisis Deepens
    Drugmaker Eli Lilly Caps Insulin Costs at $35 as CCP Virus Crisis Deepens
    Drugmaker Eli Lilly & Co. announced on April 7 that it has rolled out a scheme to cap ...
    April 8, 2020BY Isabel van Brugen
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    1hr By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    2hr By Jacki Thrapp
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    3hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    4hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    5hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    6hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    7hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    10hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    12hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    12hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top